Open AccessTreatment Trajectories During and After a Medication Trial for Opioid Use Disorder: Moving from Research as Usual to Treatment as Usual
Author(s) -
Marc Fishman,
Hoa T. Vo,
Rachael Burgower,
Michael S. Ruggiero,
John Rotrosen,
Josh Lee,
Edward V. Nunes
Publication year - 2020
Publication title -
journal of addiction medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.264
H-Index - 42
eISSN - 1935-3227
pISSN - 1932-0620
DOI - 10.1097/adm.0000000000000592
Subject(s) - medicine , opioid use disorder , buprenorphine , randomized controlled trial , naltrexone , treatment and control groups , intervention (counseling) , psychiatry , physical therapy , opioid , receptor
The effectiveness of treatment incorporating relapse prevention medications for opioid use disorder (OUD) is typically examined in research using rigidly predefined endpoints of success versus failure, usually over a single episode of care. But this perspective may not adequately portray the nonlinear trajectories typical of real-world treatment courses in this chronic, remitting, and relapsing disorder.